Journal ArticleOPEN ACCESS

Sorafenib for Advanced and Refractory Desmoid Tumors

  • Gounder M
  • Mahoney M
  • Van Tine B
  • et al.
New England Journal of Medicine (2018) 379(25) 2417-2428
DOI: 10.1056/nejmoa1805052
404Citations
Citations of this article
280Readers
Mendeley users who have this article in their library.

Abstract

Abstract Background Desmoid tumors (also referred to as aggressive fibromatosis) are connective tissue neoplasms that can arise in any anatomical location and infiltrate the mesentery, neurovascula...

Cite

CITATION STYLE

APA

Gounder, M. M., Mahoney, M. R., Van Tine, B. A., Ravi, V., Attia, S., Deshpande, H. A., … Schwartz, G. K. (2018). Sorafenib for Advanced and Refractory Desmoid Tumors. New England Journal of Medicine, 379(25), 2417–2428. https://doi.org/10.1056/nejmoa1805052

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free